Aligos Therapeutics, Inc. (ALGS) NASDAQ

4.78

-0.09(-1.85%)

Updated at May 09 10:08AM

Currency In USD

Valuation

Market Cap249.58M
Enterprise Value220.96M
P/E Ratio-0.23
PEG Ratio0
Price/Sales Ratio7.41
Price/Book Ratio-1.04
Enterprise/Revenue0.15
Enterprise/EBITDA-0.01

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-33.26
Operating Margin-22.6

Management Effectiveness

Return On Assets-1.87
Return On Equity-3.54

Income Statement

Revenue3.95M
Revenue/Share0.63
Gross Profit1.32M
EBITDA-89.15M
Net Income-131.21M
Diluted EPS-20.94

Balance Sheet

Total Cash56.94M
Total Cash/Share9.06
Total Debt8.38M
Total Debt/Equity-0.29
Current Ratio2.86
Book Value Per Share-4.61

Price History

52-Week Change-75.37
52-Week High46.8
52-Week Low3.76
Moving Average 50 Days8.54
Moving Average 200 Days16.6

Statistics

Average Volume182,540
Shares Outstanding6.11M
% Held by Institutions25.81

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:25
Last Split DateAugust 19, 2024